Issued2026-03-10

Artificial Intelligence in Healthcare Guidelines (AIHGle) 2.0

GuidanceInternational

Summary

Updated national guidance for the safe and responsible development, deployment, and use of artificial intelligence in healthcare. AIHGle 2.0 clarifies that AI should augment healthcare professionals, addresses generative AI and other developments, clarifies stakeholder responsibilities for developers, deployers, and healthcare professional users, and adds guidance on transparency, risk assessment, mitigation, and deployment governance.

Healthcare Implications

Gives Singapore healthcare institutions, clinicians, and developers a practical governance reference for building and deploying clinically safe and effective AI solutions with patient safety at the core. It is voluntary guidance, but it complements HSA software-as-medical-device regulation and should shape institutional AI governance, procurement, disclosure, risk-management, and deployment-review workflows.

Impact Level

Medium

Keywords

Transparency & Governance; Safety & Risk; Clinical Quality & Efficacy; Privacy & Data

Stakeholders

Providers & Health Systems; Developers & Vendors; Regulators & Government; Patients & Public